聚[2-(甲基丙烯酰氧)乙基三甲基氯化铵]/阿拉伯胶复凝聚法十二醇微胶囊的制备

将聚[2-(甲基丙烯酰氧)乙基三甲基氯化铵](PMTC)和阿拉伯胶(GA)在一定条件下进行了复凝聚,并对影响复凝聚实验的壁材配比、壁材浓度、离子强度等因素进行了考察.实验结果表明,PMTC与GA配比为1/3.22,壁材总浓度为4%时复凝聚效率最高;体系中不同浓度的氯化钠的存在会对复凝聚起到不同程度的抑制作用.在实验确定的最佳复凝聚条件下以有机小分子化合物十二醇作为芯材进行了包覆,制备了不同壁芯比例的微胶囊.对微胶囊的包覆率及载药量进行了测量,并对它们的释放行为进行了考察.包覆有十二醇的复合微胶囊大小一般在几微米.随着壁材与芯材比例的增大,胶囊载药量逐渐降低,微胶囊释放十二醇的速率明显变小,但包覆率却无明显变化规律.     

复凝聚法制备昆虫激素模拟物十二醇微胶囊及其释放性能

以明胶(GE)和阿拉伯胶(AG)为壁材, 通过复凝聚法将昆虫激素模拟物十二醇(C12OH)包覆在微胶囊中, 改变微胶囊壁材的浓度和交联度, 探讨了体系中C12OH的可控释放性能. 通过对壁材质量比为1及不同pH条件下的壁材凝聚率测试确定最佳复凝聚的pH为4.0; 考察了不同分散剂对微胶囊及其分散液性能的影响, 确定以Tween 20/Span 80(质量比1∶1)作为复凝聚法包覆C12OH体系的分散剂. 在壁材质量分数大于或等于3%条件下制备的微胶囊粒径大于壁材质量分数为2%的微胶囊, 胶囊的载药量和C12OH包覆率明显高于后者. 增加交联剂的用量, 壁材交联度、胶囊的载药量和C12OH包覆率都显著提高. 在相同用量的情况下, 用甲醛作交联剂时得到的微胶囊的交联度比用戊二醛作交联剂时的要低, 但其对C12OH的包覆率更高. 通过扫描电镜对微胶囊进行了分析, 认为GE与AG通过复凝聚能够将C12OH包覆在微胶囊内部. 对胶囊中C12OH在恒温恒湿条件下的释放研究结果表明, 3%与4%壁材含量下1%戊二醛交联的微胶囊和5%壁材含量下4%戊二醛交联的微胶囊中C12OH的释放行为有明显的可控性. 通过调节微胶囊的壁材含量和交联度可以达到昆虫激素可控释放的目的.     

乳清蛋白/阿拉伯胶复凝聚法制备载乙酸油酯微胶囊及其表征

油醇(十八烯醇)与乙酸酐的摩尔比为1/1.7,催化剂对甲苯磺酸用量为油醇与乙酸酐总质量的0.2%,25℃反应3h合成了昆虫性激素成分之一的乙酸油酯并对其进行了表征.以高分子电解质乳清蛋白(WP)和阿拉伯胶(GA)进行复凝聚制备聚合物微胶囊,对影响复凝聚的pH、两种电解质的配比及其浓度等因素进行了考察.结果表明在pH=3.5,WP/GA质量比1.5,WP和GA总浓度1.0%时复凝聚效果最佳.在该条件下以WP/GA为壁材对乙酸油酯进行了包覆,制备了不同壁材总浓度的载油微胶囊,对微胶囊的载油量和包覆率进行了测量.随着壁材总浓度的增大,芯材乙酸油酯包覆率呈现先上升后下降的变化趋势.用扫描电镜观察,发现制备的载乙酸油酯微胶囊大小在5～8μm并且乙酸油酯以核壳式结构的形式被包覆在微胶囊内部.     

高效氯氰菊酯微胶囊的制备、表征及释放性能

以高效氯氰菊酯为芯材, 乙基纤维素为壁材, 采用溶剂蒸发法制备了微胶囊, 并对其理化性能进行表征, 通过单因素实验研究了工艺参数对微胶囊外观形貌、 粒径大小及分布、 包封率、 载药量和缓释性能的影响. 结果表明, 乳化剂种类和剪切时间可以显著影响微胶囊的外观形貌; 随着乳化剂用量增大, 微胶囊粒径减小, 分布变窄, 当Tween-80用量从4%增加至8%时, 微胶囊平均粒径从59.9 μm减少到29.8 μm, 跨距也从1.21减少到0.72. 随着芯壁比(质量比)减小, 微胶囊粒径和包封率均逐渐增大, 载药量逐渐减小, 当芯壁比为1:1.75时, 包封率可以达到70%以上. 微胶囊释放动力学模型符合Ritger-Peppas模型(lgQ=lgk+nlgt); 平均粒径相近而载药量不同时, 初期载药量最小的样品释放速率慢, 累积释放率低; 载药量相近而平均粒径不同时, 粒径大的样品释放速率低, 累积释放率也低.     

复凝聚法辣椒油树脂微胶囊的制备

以辣椒油树脂为芯材,明胶和阿拉伯胶为壁材,采用复凝聚法制得辣椒油树脂微胶囊.考察了45℃、体系浓度为5%时,pH值、乳化剂的用量、搅拌速度等几个因素对微胶囊形成的影响.     

单凝聚与复凝聚法制备昆虫激素十二醇微胶囊及其释放行为

通过向明胶溶液中加入硫酸钠溶液的单凝聚方法以及将明胶溶液加入到阿拉伯胶溶液的复凝聚方法,制备了聚合物包覆昆虫激素十二醇的水分散体系微胶囊.通过对凝聚过程中ζ电位与透光率跟踪测试确定了单凝聚中加入硫酸钠的最佳用量以及复凝聚中明胶与阿拉伯胶的相对量.在壁材浓度大于或等于3%条件下制备的复凝聚胶囊的尺寸大于单凝聚微胶囊,但后者的大小分布更均一.除非在2%壁材浓度下,其他条件下复凝聚制备的胶囊的十二醇包覆率明显高于单凝聚胶囊.对胶囊中十二醇在恒湿恒温条件下的释放研究表明,单凝聚胶囊中十二醇很快释放完毕,变化壁材浓度不明显改变其释放行为.相比之下复凝聚胶囊中十二醇的释放对壁材浓度有明显的依赖性.2%壁材浓度制备的胶囊其释放行为类似于单凝聚胶囊;但3%到5%壁材浓度制备的胶囊中十二醇的释放明显分为3个区间,即较快的初始释放、较长时间的恒速释放以及最后阶段释放速率的再次提高直至释放完毕.复凝聚胶囊中十二醇的释放表现出了明显的可控性.文中亦对该体系中昆虫激素十二醇的释放机理作了初步讨论.     

改性胺微胶囊固化剂制备工艺的优化与性能

以改性胺1618固化剂为囊芯、脲醛树脂为壁材单体,采用界面聚合技术,成功制备了一种新型聚脲改性胺微胶囊固化剂。通过正交设计试验,考察了芯壁质量比、乳化剂种类和质量分数及搅拌速率对微胶囊包覆率、粒径大小及分布情况的影响,并确定了最佳制备工艺条件。采用马尔文激光粒度仪、扫描电镜对微胶囊粒径大小、分布情况及表面形貌进行表征,采用热重分析仪及傅里叶变换红外光谱对其化学结构进行表征,通过拉伸试验对自修复材料的断裂力学性能进行研究。结果表明,该微胶囊含有固化剂芯材,其热稳定温度为198°C,当芯壁质量比为0.7∶1、乳化剂为阿拉伯胶、乳化剂质量分数为1.5%、搅拌速率为800r/min时,所制备的微胶囊包覆率达到79.8%,平均粒径为207.5nm,呈规则的球形,分散性及表面致密性好。当基体材料中加入质量分数为1%的微胶囊后,拉伸强度提高64%,弹性模量提高287%。     

甲胺基阿维菌素苯甲酸盐微胶囊的制备与表征

以三聚氰胺-甲醛树脂为壁材,采用原位聚合法制备了甲胺基阿维菌素苯甲酸盐微胶囊,研究了三聚氰胺与甲醛的质量比、芯壁比、乳化剂、搅拌速度与时间、pH值、温度等因素对微胶囊形成的影响,对制备的微胶囊进行了表征,测定了甲维盐微胶囊化前后的光解率。结果表明,三聚氰胺与甲醛质量比为1∶2、芯材与壁材质量比为3∶2、以质量分数1%羟乙基纤维素(HEC)为乳化剂、在1000r/min搅拌速度下、pH=5.0和50℃保温2h可制备出形貌较好、平均粒径4.4μm的甲维盐微胶囊。红外光谱分析证明,甲维盐已完全被包覆在微胶囊中。紫外分光光度法测定其缓释性能良好。光解实验表明,微胶囊化可有效降低甲维盐原药的光解。     

高芯材含量聚苯乙烯石蜡微胶囊的制备及性能研究

为解决石蜡在使用过程中的一系列问题,以聚苯乙烯为壁材,58~#石蜡为芯材,采用悬浮聚合法制备了高芯材含量的微胶囊.考察了二己烯基苯(DVB)用量、芯壁比、复合改性时共聚单体种类和用量对微胶囊的影响.采用FT-IR、SEM、DSC、TG表征了微胶囊的结构、形貌、储热性能及热稳定性能.实验结果表明,DVB用量11%、芯壁比3∶1制备的微胶囊大小均匀,无团聚现象;交联改性的同时,加入20%MA单体共聚改性制备的微胶囊形貌好,热稳定性最佳,微胶囊中石蜡含量为91.7%时储热性能最优.     

以聚脲为囊壁薄荷素油微胶囊的制备及表征

采用界面聚合法,以薄荷素油为芯材,以异佛尔酮二异氰酸酯为壁材单体,在催化剂四甲基乙二胺作用下和水反应形成聚脲外壳,制备出了薄荷素油微胶囊.通过扫描电镜、激光粒度分析仪、傅里叶红外光谱仪及热重分析仪分别对香精微胶囊的表面形貌、粒径分布、单体反应情况和热稳定性进行了分析表征.通过紫外可见分光光度计对香精微胶囊包覆率进行了测定.并分析了均质化速率和微胶囊平均粒径的关系以及不同乳化剂种类和芯壁比条件下微胶囊的形貌特征.结果表明,微胶囊平均粒径随均质化速率的增大而减小,下降到1μm左右时趋于平稳,当乳化剂采用聚乙烯醇且芯壁比为4∶1时,微胶囊形貌最佳,为规整球形.最终测得微胶囊芯材包覆率为84.09 wt%,粉末状微胶囊样品含油率为72.64 wt%,并且微胶囊芯材具有良好的热稳定性.     

Microencapsulation of dodecyl acetate by complex coacervation of whey protein with acacia gum and its release behavior

Complex coacervation of whey protein(WP) with acacia gum(AG) was carried out in water with the presence of dodecyl acetate (DA),a component of insect sex pheromones,in order to obtain microcapsules with DA as the core material and WP-AG coacervate as the wall materials.Through variations in wall/core ratios,concentrations of the wall materials in capsule preparations,DA encapsulation was optimized,which showed a high DA encapsulation was achieved when coacervation was conducted at pH 3.5 with wall/core mass ratio at 3 combined with concentration of wall materials at 1.0 wt%.Morphology and the structure of DA loaded microcapsules were examined by scanning electron microscope,which showed the microcapsules were of core/shell structure with DA encapsulated in the inner of the microcapsules.DA release was examined and the behavior of the release was discussed.     

Soy glycinin microcapsules by simple coacervation method

Encapsulation of a dispersed oil phase (hexadecane) was realized by simple coacervation method using soy glycinin as the wall forming material. Suitable emulsification and coacervation conditions, that favor the formation of microcapsules wall, were identified and investigated. Mild acid (pH 2.0) and heat (55 degrees C) treatments of the reaction medium during the emulsification step enhanced significantly the deposition of coacervated glycinin around oil droplets. A pronounced correlation between glycinin concentration in the continuous phase, specific surface of the dispersed phase and the microencapsulation efficiency was also observed. Coacervation step study concerned the morphology and the stability of microcapsules. Controlled initiation of the coacervation, by slow readjustment of the pH, allowed a homogeneous precipitation of glycinin around oil droplets as well as the absence of aggregation phenomena. Since the morphology of microcapsules was considerably affected by a prolonged stirring of the reaction medium, the coacervation and reticulation time were optimized in order to preserve the homogeneity of the microcapsules size distribution and the microencapsulation efficiency.     

Preparation of PCM microcapsules by complex coacervation of silk fibroin and chitosan

Phase change material microcapsules were prepared by complex coacervation of silk fibroin (SF) and chitosan (CHI). n-Eicosane was used as the core material. The effects of SF/CHI ratio, and percentage of cross-linking agent and n-Eicosane content on the properties of microcapsules were studied. The size distribution and the surface morphology of microcapsules were characterized by optical and scanning electron microscopy. The encapsulation of core material was determined by energy dispersive spectrometer analysis. The results indicated that SF/CHI microcapsules were prepared successfully. Microcapsules had smooth outer surface when the ratio of SF to CHI was close to 5. On the other hand, at high SF/CHI ratios (≥14), microcapsules showed a two-layer structure, an inner compact layer, and an outer, more porous, sponge-like layer. The highest microencapsulation efficiency was obtained at a SF/CHI ratio of 20 in the presence of 0.9% cross-linking agent and of 1.5% n-Eicosane content.     

Permeability of dye through poly(urea-urethane) microcapsule membrane prepared from mixtures of di- and tri-isocyanate

Poly(urea-urethane) microcapsules were prepared by the interfacial polymerization with using mixtures of tri- and di-isocyanate monomers as wall forming materials, and dioctyl phthalate containing an oil-soluble dye as a core material. The time course of the dye release in dispersing tetrahydrofuran was measured as a function of the weight fraction of tri-isocyanate monomer in the total monomer w and the core/wall material-weight ratio g. The dye release curves were well represented by an exponential function C=Ceq(1-e-t/tau), where C is the concentration of the dye in the dispersing medium, Ceq that at equilibrium state, t the elution time and tau is a time constant. tau increased linearly against w at high g, suggesting controllability of the release rate of microcapsules by varying tri-isocyanate/di-isocyanate ratio.     

Microencapsulation of dichromate and paracetamol with Eudragit Retard polymers using phase separation by nonsolvent addition

A coacervation technique for microencapsulation using Eudragit Retard polymers [poly(methyl methacrylates) substituted by quaternary ammonium groups] as wall material is described, based upon phase separation using a cold chloroform-cyclohexane mixture together with polyisobutylene as a stabilizer. The effect of various parameters on the nature and properties of the microcapsules of potassium dichromate and paracetamol has been studied, in particular the alteration in wall content and structure and release rate of contents. The microcapsules are discrete, their properties are reproducible, and various degrees of sustained release are obtained.     

纳米木质素/二氧化硅基微胶囊的制备及在自愈合涂层中的应用

利用磷酸化改性木质素/二氧化硅复合纳米颗粒(PAL/SiO₂)作为壁材包埋活性组分异佛尔酮二异氰酸酯(IPDI)制备微胶囊(PAL/SiO₂-IPDI). 通过加入少量反应活性更高的聚合多甲基多二异氰酸酯(PMDI), 与水反应形成聚脲, 以增加微胶囊的壁厚. 采用光学显微镜、 扫描电子显微镜(SEM)和激光粒度分析仪(DLS)研究了PAL/SiO₂复合纳米粒子掺杂量, 水油比和剪切速率对微胶囊表面形貌、 粒径和壁厚的影响. 结果表明, 所制备的微胶囊呈现规整球形, 壁厚为2.36~3.50 μm, 平均粒径为40.3~201.5 μm. IPDI作为芯材包埋在微胶囊中, 芯材含量约为82.8%. 将制备的PAL/SiO₂-IPDI微胶囊添加到环氧树脂中得到自愈合环氧树脂涂层. 其在高盐浓度溶液中的抗侵蚀测试结果显示, 添加质量分数4%的PAL/SiO₂-IPDI微胶囊的环氧树脂涂层在划破后能够快速愈合, 显著降低基底的腐蚀电流和腐蚀速率. 纳米压痕实验表明, 环氧涂层的硬度为249.99 MPa, 而添加PAL/SiO₂-IPDI微胶囊后硬度增加到302.98 MPa, 弹性模量也有提高.